The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis
Abstract
The rapidly changing landscape of cannabis in terms of availability, potency, and routes of administration, as well as the decrease in risk perception and changing norms, have contributed to an increase in the popularity of cannabis. Cannabis use is associated with a poorer recovery from a psychotic disorder, increasing the risk of relapse, rehospitalization, and lower social functioning. Data are mixed regarding cannabis use as a component cause of psychosis in people at risk for psychotic disorder. Care providers, parents, and schools must educate youth and adolescents about the risks of cannabis use.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The risk of psychosis appears to be influenced by the age of the individual at first use, the potency of the cannabis used, and how frequently it is used.
“The risk of psychosis appears to be influenced by the age of the individual at first use, the potency of the cannabis used, and how frequently it is used.”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [130]
The relationship between cannabis use and psychosis is likely multidirectional, and its exact mechanisms continue to be debated.
“This is likely a multidirectional relationship, and its exact mechanisms continue to be a subject of debate 130 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [130]
The citation lists haven’t been fetched yet
References 101 · Cited by 16
- Authors
- Wright, A., Cather, C., Gilman, J., & Evins, A. E.
- Affiliations
- Harvard University (US)
- Corresponding author
- Wright, Abigail
- Venue
- Child and Adolescent Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 29
- Issue
- 1
- Pages
- 145-156
- ISSN
- 1056-4993 (ISSN-L)
- OpenAlex
- W2979915752
- Cited by
- 16
- References
- 101
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 5
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Child and Adolescent Psychiatric Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- cannabis use, psychosis risk, cannabis potency, route of administration, risk perception, relapse, hospital readmission, social functioning
- MeSH terms
- Marijuana Use, Adolescent, Child, Humans, Psychotic Disorders, Schizophrenia, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
